An array of pharmaceutical formulations characterized by the presence of molecular oxygen comprising four elements which, in combination, furnish benefits for the health of patients with HIV AIDS: (i) weight increase of the patient； (ii) increase of appetite； (iii) reduction of diarrhea； (iv) reduction of the wasting syndrome； (v) increase of stability of mood； (vi) increase of muscular mass. (vii) decrease of opportunistic diseases, in particular infections caused by Candida, herpes virus, cytomegalovirus, Kaposi's sarcoma； (viii) prolongation of the period wherein the patient does not require to take antiretrovirals； (ix) increase of acceptance of pharmacological treatment； x. reduction of gastritis, nausea or vomiting, headache； (xi) reduction of cases with anemia or thrombocytopenia； and (xii) a change in the phase of the disease in the patient.
